Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19.
Am J Trop Med Hyg
; 102(6): 1214-1216, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: covidwho-602004
ABSTRACT
Hydroxychloroquine (HCQ) has been used for the treatment of novel coronavirus disease (COVID-19) cases. However, evidence of efficacy remains limited, and adverse events can be associated with its use. Here, we report a case of a patient with severe COVID-19 who, after being administered HCQ, exhibited a 10-fold increase in serum levels of transaminases, followed by a rapid decrease after HCQ was withdrawn. Considering the significantly increased use of HCQ during the COVID-19 pandemic, this case alerts us to the potential for HCQ to be associated with hepatotoxicity and the need to monitor liver function during HCQ therapy.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Infecciones por Coronavirus
/
Betacoronavirus
/
Hidroxicloroquina
/
Hígado
Tipo de estudio:
Reporte de caso
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Am J Trop Med Hyg
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Ajtmh.20-0276
Similares
MEDLINE
...
LILACS
LIS